Retinal Microvascularization in OCT-angiography and Systemic Diseases

Recruiting Observational Study
Systemic Vascular Damage
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Systemic diseases are inflammatory, chronic illnesses affecting different organs and altering their function. At present, there are few non-invasive methods for predicting their onset and progression. Some chronic diseases can be anticipated earlier thanks to predictive indicators. These indicators could help doctors decide which treatment is best suited to each patient. In particular, the state …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: For the \"patients with systemic vascular disease\" group * Patients who have given oral, free and informed consent * Patients with either : * systemic vascular pathology * high cardiovascular risk * inflammatory vascular pathology * preeclampsia during pregnan…
Contacts

Louis ARNOULD

0380293453

Louis.arnould@chu-dijon.fr

CONTACT